Samuel, Samson Mathews <br/><br/>
Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.  [electronic resource] 

 -  Diabetes  Jan 2010 
 - 51-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1939-327X 
<br/><br/><label>Standard No.: </label>10.2337/db09-0336  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae<br/>Angiopoietin-1--administration & dosage<br/>Animals<br/>Capillaries--drug effects<br/>Diabetes Mellitus, Experimental--complications<br/>Diabetic Angiopathies--drug therapy<br/>Heart Ventricles--drug effects<br/>Humans<br/>Male<br/>Microtubule-Associated Proteins--drug effects<br/>Myocardial Infarction--physiopathology<br/>Rats<br/>Receptor, TIE-2--drug effects<br/>Survivin<br/>Vascular Endothelial Growth Factor A--administration & dosage<br/>Vascular Endothelial Growth Factor Receptor-2--drug effects<br/>Ventricular Remodeling--drug effects